Daily as of 3 Nov 16:00 ET
- Price
- below both $21.55 vs 50 $57.05 / 200 $72.61
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 14 Jul 2026 · projected 26 bars out · tested 6 bars
DRUG | Bright Minds BiosciencesNASDAQCommon stock golden cross and death cross projections, cross tests and history
$21.55
-$4.65 (-17.75%)
Bright Minds Biosciences (DRUG) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2022.
The 50 SMA has sat below the 200 on the daily since Jul 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $54.98 vs 50 $73.70 / 200 $30.63
- Projection
- No cross projected
- Test
- No active test
- Last cross
- No cross on record
4-hour as of 3 Nov 13:30 ET
- Price
- below both $22.81 vs 50 $50.76 / 200 $65.02
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 9 Sep 2026 · projected 14 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 9 Sep 2026 | 💀Death | 4-hour | 14 bars out | — |
| 1 Sep 2026 | 🟨Golden | 4-hour | 18 bars out | Not tested |
| 14 Jul 2026 | 💀Death moderate | daily | 26 bars out | 6 bar cross test |
| 9 Jun 2026 | 💀Death | 4-hour | 24 bars out | Not tested |
| 28 Apr 2026 | 🟨Golden | 4-hour | 29 bars out | 1 bar cross test |
About DRUG
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$5.9M
4-hour coverageYes, since Oct 2025
History on recordSince 2022
Cap bandsmall